7 Questions Every Beauty Investor Must Ask
Before the term sheet. Before the wire. Before it's too late.
Beauty investing looks approachable. What doesn't show up in the pitch deck is the operational and regulatory complexity underneath—the classification errors, the documentation gaps, the supply chain assumptions that hold until they don't.
Send Me the Brief
Enter your email to receive the brief. Free. No spam.
Who am I?
Melory Johnson is a beauty industry veteran with 25+ years of experience across product development, regulatory compliance, manufacturing, and commercialization. Pretty Equity is her advisory and publishing platform — translating that experience into tools, research, and insight for investors and founders navigating beauty execution risk.
What will you learn?
This brief covers the 7 questions designed to surface the operational and regulatory risks most diligence processes miss — before the term sheet, before the wire, before it's too late. Topics include regulatory classification, safety and stability testing, GMP and manufacturing, documentation and IP control, claims defensibility, supply chain concentration risk, and scale readiness.
© 2026 All rights reserved